Alvotech
31.00 SEK
+1.47 %
Less than 1K followers
ALVO SDB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
+1.47 %
-10.53 %
-19.52 %
-33.25 %
-38.58 %
-67.18 %
-
-
-68.46 %
Alvotech is a biotechnology company that focuses on the development and manufacture of biosimilar medicines. The company's pipeline consists of biosimilar candidates aimed at treating autoimmune diseases, eye diseases, osteoporosis and cancer. The company offers its products to patients all over the world. Alvotech was founded in 2013 and has its headquarters in Reykjavík.
Read moreMarket cap
10.74B SEK
Turnover
170.17K SEK
Revenue
5.39B
EBIT %
13.34 %
P/E
33.71
Dividend yield-%
-
Revenue and EBIT-%
Revenue B
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.8
2026
Interim report Q2'26
12.11
2026
Interim report Q3'26
11.3
2027
Annual report '26
All
Press releases
ShowingAll content types
Alvotech Q1 2026 Financial Results
Alvotech Announces a Change in its Executive Team
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools